HighPeak Energy Posts Lower Q1 Net Income, Revenue-February 2024-www.financetom.com

HighPeak Energy Posts Lower Q1 Net Income, Revenue

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

HighPeak Energy Posts Lower Q1 Net Income, Revenue

May 26, 2025 6:18 AM

05:11 PM EDT, 05/12/2025 (MT Newswires) -- HighPeak Energy ( HPK ) reported late Monday Q1 adjusted net income of $0.31 per diluted share, down from $0.37 a year earlier.

Operating revenue for the quarter ended March 31 was $257.45 million, down from $287.76 million a year earlier. Analysts polled by FactSet expected $249.2 million.

Previous page： Cogent Biosciences posts wider Q3 loss as costs rise Next page： Pagaya, Castlelake reach deal for up to $500 million in auto loans

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Cogent Biosciences posts wider Q3 loss as costs rise

Nov 3, 2025

Overview * Cogent Biosciences ( COGT ) reports Q3 net loss of $80.9 mln, up from $70.6 mln in 2024 * Cash position of $390.9 mln expected to fund operations through 2027 * Upcoming PEAK and APEX trial results expected in Nov and Dec 2025 Outlook * Cogent plans to announce PEAK trial results in November 2025 * Company expects...

Pagaya, Castlelake reach deal for up to $500 million in auto loans

Nov 3, 2025

WASHINGTON, Nov 3 (Reuters) - Lending platform Pagaya Technologies ( PGY ) on Monday announced an agreement to sell up to $500 million of its auto loans to asset-based private credit manager Castlelake. In a statement, New York City-based Pagaya ( PGY ) said the deal has the potential to significantly accelerate Pagaya's ( PGY ) auto lending platform. The...

Alexander's Q3 Adjusted FFO Increases, Revenue Decreases

Nov 3, 2025

09:08 AM EST, 11/03/2025 (MT Newswires) -- Alexander's (ALX) reported Q3 adjusted funds from operations Monday of $2.91 per diluted share, up from $2.84 a year earlier. A single analyst polled by FactSet expected $2.13. Rental revenue for the quarter ended Sept. 30 was $53.4 million, down from $55.7 million a year earlier. A single analyst surveyed by FactSet expected...

Iradimed Q3 Non-GAAP Earnings, Revenue Rise; Q4 Outlook Issued, 2025 Outlook Raised

Nov 3, 2025

09:10 AM EST, 11/03/2025 (MT Newswires) -- Iradimed ( IRMD ) reported Q3 non-GAAP earnings Monday of $0.47 per diluted share, up from $0.43 a year earlier. Two analysts polled by FactSet expected $0.46. Revenue for the quarter ended Sept. 30 was $21.2 million, compared with $18.3 million a year earlier. Two analysts surveyed by FactSet expected $20.5 million. The...